Contrave Weight Loss Results Contrave produces moderate weight loss: COR (Contrave Obesity Research) trials: COR-I trial: 6.1% average weight loss at 56 weeks (vs
It upregulates genes associated with tissue repair and regeneration while downregulating genes associated with inflammation and tissue destruction
no significant differences were seen between user and non-user groups, with 33% of both having escalations, and slightly more of the non-users having de-escalations (16% vs 7%)
In general terms, initial dosing tends to begin at the lower end of an established range to assess tolerability, with adjustment directed by the provider based on response and side effects
Product Information Compound Name CJC 1295 (No DAC) and Ipamorelin Net Content 10 mg total peptide content Composition CJC 1295 (No DAC) 5 mg Ipamorelin 5 mg Purity Greater than 99 percent (HPLC verified) Form Lyophilized peptide blend Storage Store unreconstituted material at ?20C for long term stability
Access code for resbiotic portal Resbiotic Access Code Access code for the portal
